Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Hormone therapy using tamoxifen may fight breast cancer by blocking
the uptake of estrogen by the tumor cells. Combining chemotherapy with hormone therapy may
kill more tumor cells.
PURPOSE: Randomized phase III trial to compare the effectiveness of epirubicin and tamoxifen
with or without docetaxel in treating postmenopausal women who have breast cancer that has
spread to the lymph nodes.